Jon David Gaffaney, Ph.D.

Affiliations: 
Neuroscience University of Wisconsin, Madison, Madison, WI 
Area:
membrane fusion
Google:
"Jon Gaffaney"
Mean distance: 15.95 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chang CW, Chiang CW, Gaffaney JD, et al. (2015) Lipid-anchored synaptobrevin provides little or no support for exocytosis or liposome fusion. The Journal of Biological Chemistry
Xue R, Gaffaney JD, Chapman ER. (2015) Structural elements that underlie Doc2β function during asynchronous synaptic transmission. Proceedings of the National Academy of Sciences of the United States of America. 112: E4316-25
Gaffaney JD, Xue R, Chapman ER. (2014) Mutations that disrupt Ca²⁺-binding activity endow Doc2β with novel functional properties during synaptic transmission. Molecular Biology of the Cell. 25: 481-94
Gaffaney JD, Shetty M, Felts B, et al. (2014) Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge. Neurochemistry International. 73: 16-26
Yao J, Kwon SE, Gaffaney JD, et al. (2012) Uncoupling the roles of synaptotagmin I during endo- and exocytosis of synaptic vesicles. Nature Neuroscience. 15: 243-9
Yao J, Gaffaney JD, Kwon SE, et al. (2011) Doc2 is a Ca2+ sensor required for asynchronous neurotransmitter release. Cell. 147: 666-77
Hui E, Gaffaney JD, Wang Z, et al. (2011) Mechanism and function of synaptotagmin-mediated membrane apposition. Nature Structural & Molecular Biology. 18: 813-21
Gaffaney JD, Dunning FM, Wang Z, et al. (2008) Synaptotagmin C2B domain regulates Ca2+-triggered fusion in vitro: critical residues revealed by scanning alanine mutagenesis. The Journal of Biological Chemistry. 283: 31763-75
Parnas ML, Gaffaney JD, Zou MF, et al. (2008) Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites. Molecular Pharmacology. 73: 1141-50
Vaughan RA, Parnas ML, Gaffaney JD, et al. (2005) Affinity labeling the dopamine transporter ligand binding site. Journal of Neuroscience Methods. 143: 33-40
See more...